Amarin Corporation plc (AMRN)
NASDAQ: AMRN · Real-Time Price · USD
0.460
-0.006 (-1.18%)
At close: Dec 20, 2024, 4:00 PM
0.490
+0.030 (6.50%)
After-hours: Dec 20, 2024, 6:58 PM EST

Amarin Corporation Revenue

Amarin Corporation had revenue of $42.30M in the quarter ending September 30, 2024, a decrease of -35.97%. This brings the company's revenue in the last twelve months to $241.02M, down -25.25% year-over-year. In the year 2023, Amarin Corporation had annual revenue of $306.91M, down -16.87%.

Revenue (ttm)
$241.02M
Revenue Growth
-25.25%
P/S Ratio
0.78
Revenue / Employee
$876,440
Employees
275
Market Cap
189.22M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023306.91M-62.28M-16.87%
Dec 31, 2022369.19M-213.99M-36.69%
Dec 31, 2021583.19M-30.87M-5.03%
Dec 31, 2020614.06M184.31M42.89%
Dec 31, 2019429.76M200.54M87.49%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Accuray 444.20M
ADC Therapeutics 70.72M
Fate Therapeutics 13.45M
Verastem 10.00M
Orchestra BioMed Holdings 2.65M
Quantum-Si incorporated 2.27M
Revenue Rankings